ITCI Intra-Cellular Therapies
- 71.881
- -0.249-0.35%
Intra-Cellular Therapies News
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Hineline Lawrence J.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Durgam Suresh K.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Hineline Lawrence J.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Durgam Suresh K.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Hineline Lawrence J.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Durgam Suresh K.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Analysis
Price Target
No Data
